EndoCure
EndoCure is transforming an off-the-shelf ultrasound into an AI-enabled, objective, high-res 3D tool
StartupEndoCure is a Haifa-based startup in the Health Tech & Life Sciences sector, established in 2023. EndoCure is transforming an off-the-shelf ultrasound into an AI-enabled, objective, high-res 3D tool. The company has raised a total of $2.55M across 6 funding rounds, currently at the Pre-Seed stage. EndoCure was founded by Hadas Ziso and Moshe Shoham. The company has 1-10 employees. Core technologies: Artificial Intelligence, Machine Learning, Image Recognition, Computer Vision, Sensing, Motion, Simulation & Imaging, Ultrasound.
With $2.55M in total funding, EndoCure is a Pre-Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StagePre-Seed
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQHaifa
- DistrictEngland
- Last Round$500K
Hadas ZisoCo-founder & CEO
Moshe ShohamCo-Founder
6 articles covered by sources including www.israel21c.org,
www.femtechworld.co.uk,
www.techtruster.dk,
www.calcalistech.com,
www.calcalist.co.il.
What does EndoCure do?
Chronic conditions like cancer and endometriosis remain difficult to diagnose accurately due to the limitations of current imaging tools. Cancer is the most misdiagnosed of the 'big three' conditions, and 75% of endometriosis patients receive an incorrect diagnosis and are forced to undergo diagnostic surgery. While MRI and PET-CT often miss small findings, ultrasound is highly operator-dependent and inconsistent, leaving a critical gap in the early and reliable detection of disease. Revealan™, our robotic ultrasound imaging platform, seamlessly integrates with any off-the-shelf ultrasound device to enable operator-agnostic, automated, AI-enabled, high-resolution 3D imaging. The robotic scan output is a series of standardized medical images with a density 10 times higher than that of an MRI. With Revealan™, we allow early detection and reliable follow-ups of small findings. Revealan™ is optimizing ultrasound for better patient outcomes.
How much funding has EndoCure raised?
EndoCure has raised $2.55M in total funding across 6 rounds. The company is currently at the Pre-Seed stage.
Who founded EndoCure?
EndoCure was founded in 2023 by Hadas Ziso (Co-founder & CEO), Moshe Shoham (Co-Founder).
What sector is EndoCure in?
EndoCure operates in Health Tech & Life Sciences, Medical Devices, with core technologies in Artificial Intelligence, Machine Learning, Image Recognition, Computer Vision, Sensing, Motion, Simulation & Imaging, Ultrasound. Target customers: Healthcare & Life Sciences, Healthcare, Insurance Companies, Patients, Providers, Medical Devices Industry.
Where is EndoCure located?
EndoCure is based in Haifa, Israel, England.